Your browser doesn't support javascript.
loading
Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials.
Biesma, Hedde D; Soeratram, Tanya T D; Sikorska, Karolina; Caspers, Irene A; van Essen, Hendrik F; Egthuijsen, Jacqueline M P; Mookhoek, Aart; van Laarhoven, Hanneke W M; van Berge Henegouwen, Mark I; Nordsmark, Marianne; van der Peet, Donald L; Warmerdam, Fabienne A R M; Geenen, Maud M; Loosveld, Olaf J L; Portielje, Johanneke E A; Los, Maartje; Heideman, Daniëlle A M; Meershoek-Klein Kranenbarg, Elma; Hartgrink, Henk H; van Sandick, Johanna; Verheij, Marcel; van de Velde, Cornelis J H; Cats, Annemieke; Ylstra, Bauke; van Grieken, Nicole C T.
  • Biesma HD; Department of Pathology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
  • Soeratram TTD; Department of Pathology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
  • Sikorska K; Department of Biometrics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Caspers IA; Department of Pathology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
  • van Essen HF; Department of Gastrointestinal Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Egthuijsen JMP; Department of Pathology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
  • Mookhoek A; Department of Pathology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
  • van Laarhoven HWM; Department of Pathology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
  • van Berge Henegouwen MI; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Nordsmark M; Department of Surgery, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • van der Peet DL; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Warmerdam FARM; Department of Surgery, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.
  • Geenen MM; Department of Medical Oncology, Zuyderland Hospital, Sittard, The Netherlands.
  • Loosveld OJL; Department of Medical Oncology, OLVG, Amsterdam, The Netherlands.
  • Portielje JEA; Department of Medical Oncology, Amphia Hospital, Breda, The Netherlands.
  • Los M; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Heideman DAM; Department of Medical Oncology, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Meershoek-Klein Kranenbarg E; Department of Pathology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
  • Hartgrink HH; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • van Sandick J; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Verheij M; Department of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • van de Velde CJH; Department of Radiation Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Cats A; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Ylstra B; Department of Gastrointestinal Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • van Grieken NCT; Department of Pathology, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Gastric Cancer ; 25(3): 640-651, 2022 05.
Article en En | MEDLINE | ID: mdl-35129727

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Infecciones por Virus de Epstein-Barr Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Infecciones por Virus de Epstein-Barr Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article